Key result
Infancy links to ~19-fold greater odds of left ventricular endocardial fibroelastosis in pediatric DCM explants.
Why the study?
Endocardial fibroelastosis is a recognized pathological finding in pediatric dilated cardiomyopathy, but its prognostic significance and the nature of its association remain unknown.
What is the frequency and association of left ventricular endocardial fibroelastosis in pediatric dilated cardiomyopathy explants across different age groups?
Observational (n=89)
What is the frequency and association of left ventricular endocardial fibroelastosis in pediatric dilated cardiomyopathy explants across different age groups?
Endocardial fibroelastosis is a highly common pathological finding in pediatric dilated cardiomyopathy explants, particularly in infants and young children.
Answers are grounded in this paper and cite their sources.
High prevalence in young explants warrants histologic attention; leaves open mechanistic and prognostic roles in pediatric DCM.
Heart failure due to dilated cardiomyopathy is a major indication for paediatric cardiac transplantation. Endocardial fibroelastosis is a recognised pathological finding of unknown prognostic significance in paediatric dilated cardiomyopathy. To evaluate the nature of the association between left ventricular endocardial fibroelastosis and paediatric dilated cardiomyopathy, we reviewed surgical pathology reports of dilated cardiomyopathy explants (1986-2016) in order to characterise the pathological findings and to compare and contrast their frequency among four age groups: less than 1 year; 1-5 years; 6-10 years; and greater than 11 years. The 89 explants (47 males and 42 females) were all characterised by increased weight and left ventricular chamber dilatation without increased wall thickness. Ninety-five per cent of the specimens in the two youngest subsets had left ventricular endocardial fibroelastosis. Compared to the oldest age group, recipients aged 1-5 years had a 6-fold increase and those younger than 1 year a 19-fold increase in the odds of observing left ventricular endocardial fibroelastosis. Explants with and without endocardial fibroelastosis were otherwise phenotypically similar. In paediatric dilated cardiomyopathy endocardial fibroelastosis is a very common pathological finding, especially in infants and young children. We propose that the descriptive, clinico-pathological designation "Dilated Cardiomyopathy with Endocardial Fibroelastosis" should be adopted to facilitate future investigation into the potential prognostic/therapeutic significance of left ventricular endocardial fibroelastosis.
No takes yet. Share an insight, caveat, or question.
Reyes et al. (2021) conducted an observational in Paediatric dilated cardiomyopathy (n=89). Age <1 year vs. Age >11 years was evaluated on Presence of left ventricular endocardial fibroelastosis (OR 19). Left ventricular endocardial fibroelastosis was present in 95% of dilated cardiomyopathy explants from children ≤5 years, with a 19-fold increased odds in infants <1 year versus the oldest group.
Synapse has enriched 10 related papers. Consider them for comparative context: